Blood cancer dosing trial aims to Fine-Tune treatment

NCT ID NCT07474961

First seen Mar 17, 2026 · Last updated May 14, 2026 · Updated 14 times

Summary

This study is for adults with blood cancers like multiple myeloma or Waldenstrom macroglobulinaemia. It compares different treatment doses to see which works best and has the fewest side effects. The goal is to improve survival and quality of life by finding the optimal dose for each patient.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aalborg University Hospital

    Aalborg, 9000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Aarhus University Hospital

    Aarhus, 8200, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Copenhagen University Hospital - Rigshospitalet

    Copenhagen, Greater Copenhagen Area, 2100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Odense University Hospital

    Odense, 5000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Roskilde University Hospital

    Roskilde, 4000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.